In addition, luciferase reporter assays were performed to validate the predicted target genes of miR‑222. miR‑222 was significantly upregulated in patients with IDD.
In addition, two important microRNAs (microRNA‑222 and microRNA‑589) were identified that were pivotal for the development of IDD, and their target genes, CDKNAB and SMAD4.